Effects of leucine supplemented diet on intestinal absorption in tumor bearing pregnant rats

BMC Cancer

Table 1 Body weight gain (total body weight on 20^th day), food intake, tumor weight/carcass weight, fetal weight of the groups studied.

	Body weight gain (%)	Food intake (%)	Tumor weight/carcass weight (%)	Fetal weight (g)
C	30,21 ± 0,27	98,77 ± 4,55
N	45,02 ± 1,32 a	95,75 ± 4,85		3,73 ± 0,13
WN	22,83 ± 0,53 b	40,01 ± 3,56 ab	7,81 ± 0,27	1,61 ± 0,22 b
Np	26,01 ± 1,07 b			2,98 ± 0,34
L	43,19 ± 1,30 a	82,40 ± 8,64		3,45 ± 0,16
WL	24,87 ± 0,61 b	41,29 ± 3,63 ab	7,46 ± 0,33	1,15 ± 0,16 b
Lp	26,78 ± 0,44 b			2,77 ± 0,44

Body weight gain was determined from the rate final body weight gain in relation to initial body weight gain (%). Food intake was expressed as a percentage of initial and final food intake (%) Data are reported as means ± SE from 10 animals per group. Groups: control (C); pregnant control (N); pregnant tumor-bearing (WN); pregnant control pair-fed to tumor-bearing groups (Np); pregnant control receiving a leucine supplemented diet (L), pregnant tumor-bearing receiving a leucine supplemented diet (WL) and pregnant control leucine pair-fed group (Lp). a p < 0,05 compared to control group (C); b p < 0,05 N vs WN and L vs WL.

ISSN: 1471-2407